MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Kinematic Features of Voluntary and Involuntary Head Movements in Cervical Dystonia

    T. Hart, L. Heideman, D. Martino, M. Beudel, A. Sadnicka, F. Morgante (London, United Kingdom)

    Objective: To identify kinematic metrics that characterise and differentiate the motor manifestations of Cervical Dystonia (CD). Background: Motor manifestations of CD include phasic torsional movements,…
  • 2024 International Congress

    Longitudinal Assessment of Dystonic Symptoms in Rapid-Onset Dystonia-Parkinsonism: genetic dystonia symptoms vary over time

    I. Haq, V. Wheelock, L. Ozelius, B. Snively, E. Napoli, K. Sweadner, A. Brashear (Miami, USA)

    Objective: To clarify the temporal progression of symptoms in the rare genetic dystonia, ATP1A3 disease Background: The ATP1A3 gene encodes the neuronally ubiquitous α3 subunit…
  • 2024 International Congress

    Severe Acute Spinal Cord Injury Due to Isolated Generalized Dystonia

    A. Eid, J. Perlmutter (Saint Louis, USA)

    Objective: To report a case of isolated generalized dystonia causing severe cervical trauma Background: Rotational forces on the cervical spine leading to injury is a…
  • 2024 International Congress

    Association between Morbidity and Social Vulnerability in Patients with Huntington Disease

    J. Patino, N. Rocha, S. Zadegan, B. Duncan, R. Ramphul, A. Sharrief, E. Furr Stimming (Houston, USA)

    Objective: To investigate how social vulnerability affects clinical outcomes in Huntington disease (HD) gene expansion carriers (HDGECs). Background: Social determinants of health (SDOH) are nonmedical…
  • 2024 International Congress

    Treatment Effect Sizes of Once-Daily Valbenazine for Tardive Dyskinesia and for Chorea Associated with Huntington’s Disease: A Post-Hoc Analysis of Phase 3 Clinical Trial Data

    R. Mehanna, R. Hauser, E. Furr Stimming, L. Citrome, E. Kayson, J. Goldstein, O. Klepitskaya, S. Hinton, H. Zhang, E. Dunayevich, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To assess the treatment effect size of once-daily valbenazine for tardive dyskinesia (TD) and for chorea associated with Huntington’s disease (HD) using data from…
  • 2024 International Congress

    Shifting Paradigms In Huntington’s Disease Research: A Five-Year Scopus-Based Bibliometric Exploration

    RN. Surbakti, RK. Praja (Palangka Raya, Indonesia)

    Objective: This study aimed to investigate the shifting trends (2019-2024) in research on Huntington's disease (HD)based on bibliometric lens. Background: Huntington's disease is a movement…
  • 2024 International Congress

    Racial Disparities in Hospitalization Characteristics among Native Hawaiians, Pacific Islanders and Asian American Subgroups with Restless Legs Syndrome

    L. Terpak, M. Matsunaga, E. Krening, M. Bruno (Honolulu, USA)

    Objective: To determine if patient characteristics differ among Native Hawaiians/Pacific Islanders (NHPI), Asian American (AA) subgroups, and Whites who were hospitalized with Restless Leg Syndrome…
  • 2024 International Congress

    Goal Attainment and Ambulation With Increasing Doses of IncobotulinumtoxinA: A Post Hoc Analysis of the TOWER Study

    D. Bensmail, K. Fheodoroff, A. Hanschmann, L. Nicolson, W. Clarke, M. Vacchelli, J. Wissel (Garches, France)

    Objective: To evaluate goal attainment and ambulation in a subpopulation of TOWER study patients treated with UK licensed doses of incobotulinumtoxinA (incoA) for injection cycles…
  • 2024 International Congress

    Validation of a New Patient-reported Outcome Scale for the Assessment of Essential Tremor

    L. Shih, M. Stevenson, S. Bellows, A. Fasano, S. Kuo, K. Lyons, H. Moore, H. Shill, A. Shukla, C. Singer, R. Elble (Boston, USA)

    Objective: Develop and validate a TETRAS PRO subscale Background: The Essential Tremor Rating Assessment Scale (TETRAS) is a popular scale for essential tremor (ET), but…
  • 2024 International Congress

    Treatment Patterns in Essential Tremor: Real-World Evidence from Germany

    JS. Becktepe, S. Müller, T. Wilke, E. Zhuleku, K. Appiah, K. Mcdonald, N. Dzimitrowicz, J. Marshall, J. Sabater, LM. Barbato, TA. Saifee (Kiel, Germany)

    Objective: To investigate the treatment patterns (TP), healthcare resource utilization (HCRU), and costs of essential tremor (ET) in a real-world setting in Germany using insurance…
  • « Previous Page
  • 1
  • …
  • 52
  • 53
  • 54
  • 55
  • 56
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley